Finance

Beta
Lists
BONEX:STO
Bonesupport Holding AB
SEK 260.80
+0.85%
(+2.20) 1D
May 21, 5:29:42 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BONEX...
Open
SEK 259.40
High
SEK 266.00
Low
SEK 257.20
Mkt. cap
17.03B
Avg. vol.
286.26K
Volume
198.60K
52-wk high
SEK 346.40
52-wk low
SEK 165.00
Shares outstanding
65.86M
No. of employees
160
News stories
From sources across the web
Profile
BoneSupport AB is a Swedish biotech company active at the Ideon Science Park in the university town of Lund in Skåne, Sweden, founded in 1999 by Lars Lidgren, Professor of Orthopedic Surgery and Academic Head of Department at Lund University Hospital in Sweden which is a member of the ISOC group of orthopaedic centers. The company has been funded with more than SEK 500 million in venture capital from inter alia HealthCap, Lundbeck foundation and Industrifonden, making it one of the largest ventures in the Swedish medical technologies industry. Wikipedia
About Bonesupport Holding AB
CEOEmil Billbäck
Employees160
Founded1999
Headquarters-
SectorBiotechnology
Websitebonesupport.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
284.42M
294.14M
312.55M
324.02M
Cost of goods sold
21.82M
20.93M
23.58M
25.11M
Cost of revenue
21.82M
20.93M
23.58M
25.11M
Research and development expenses
23.58M
20.55M
23.45M
25.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
172.75M
181.61M
185.97M
201.00M
Operating expense
196.33M
202.16M
208.53M
226.76M
Total operating expenses
218.15M
223.09M
232.11M
251.87M
Operating income
66.28M
71.05M
80.44M
72.16M
Other non operating income
-
-
-
-
EBT including unusual items
51.14M
66.77M
68.52M
68.02M
EBT excluding unusual items
51.14M
66.77M
63.61M
68.02M
Income tax expense
-1.93M
32.26M
24.37M
14.64M
Effective tax rate
-3.78%
48.32%
35.57%
21.53%
Other operating expenses
-
-
-887.00K
706.00K
Net income
53.07M
34.51M
44.15M
53.38M
Net profit margin
18.66%
11.73%
14.13%
16.47%
Earnings per share
0.91
0.62
0.66
0.80
Interest and investment income
-
1.38M
7.27M
-
Interest expense
-3.74M
-
-20.51M
-4.13M
Net interest expenses
-3.74M
1.38M
-13.24M
-4.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
66.82M
71.60M
80.97M
72.69M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer